Two new vasopressin antagonists, conivaptan and tolvaptan have recently been licensed for the treatment of hyponatremia in the USA. Their safety and clinical effectiveness seems promising, but high costs and the lack of data regarding their use in symptomatic patients call for further studies to clarify their future clinical role.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rozen-Zvi, B. et al. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am. J. Kidney Dis. 56, 325–337 (2010).
Sterns, R. H., Nigwekar, S. U. & Hix, J. K. The treatment of hyponatremia. Semin. Nephrol. 29, 282–299 (2009).
Velez, J. C., Dopson, S. J., Sanders, D. S., Delay, T. A. & Arthur, J. M. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol. Dial. Transplant. 25, 1524–1531 (2010).
Sterns, R. H., Hix, J. K. & Silver, S. Treating profound hyponatremia: a strategy for controlled correction. Am. J. Kidney Dis. 56, 774–779 (2010).
Mohmand, H. K. et al. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin. J. Am. Soc. Nephrol. 2, 1110–1117 (2007).
Perianayagam, A. et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3, 331–336 (2008).
Berl, T. et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J. Am. Soc. Nephrol. 21, 705–712 (2010).
Renneboog, B. et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am. J. Med. 119, 71 e71–e78 (2006).
Verbalis, J. G. et al. Hyponatremia-induced osteoporosis. J. Bone Miner. Res. 25, 554–563 (2010).
Waikar, S. S., Mount, D. B. & Curhan, G. C. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am. J. Med. 122, 857–865 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R. Sterns has received honoraria as a speaker in symposia sponsored by Astellas and Otsuka. J. Hix declares no competing interests.
Rights and permissions
About this article
Cite this article
Sterns, R., Hix, J. Vasopressin antagonists in hyponatremia: more data needed. Nat Rev Nephrol 7, 132–133 (2011). https://doi.org/10.1038/nrneph.2010.173
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.173